Merkel cell carcinoma patients with solid organ transplant or hematologic malignancy: Demographics, survival, and prognosticators - 14/05/22
Doi : 10.1016/j.jaad.2021.05.042
Nolan J. Maloney, MD a, b, Jason J. Yang, BS a, b, Lisa C. Zaba, MD, PhD a, b, ⁎ 
a Veterans Affairs Palo Alto Healthcare System, Palo Alto, California
b Department of Dermatology, Stanford University School of Medicine, Palo Alto, California
∗Correspondence to: Lisa Zaba, MD, PhD, Department of Dermatology, Stanford University, 780 Welch Road, Palo Alto, CA 94304Department of DermatologyStanford University780 Welch RoadPalo AltoCA94304
Graphical abstract |
| Funding sources: Stanford Cancer Institute Cancer Center Support Grant of the National Institutes of Health under Award No. P30 CA124435. |
|
| IRB approval status: Approved by the Stanford University Institutional Review board (59723). |
|
| Reprints not available from the authors. |
© 2021
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 86 - N° 6
P. 1385-1387 - giugno 2022 Ritorno al numero
Articolo precedente
- Health-related domains of quality of life in pyoderma gangrenosum: A qualitative analysis
- Kelsey B. Nusbaum, Alex G. Ortega-Loayza, Benjamin H. Kaffenberger
- Neutrophil to lymphocyte ratio is predictive of severe complications and mortality in patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid: A retrospective longitudinal observational study
- Seiko Sugiyama, Takenobu Yamamoto, Yumi Aoyama
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?